The proinflammatory cytokine interleukin-1 (IL-1) signals via type I IL-1 receptor (IL-1RI) and IL-1 receptor accessory protein (IL1RAP), which leads to activation of the transcription factor NF-κB and induction of a range of downstream proteins involved in inflammatory and immune responses. Here, we identified the E3 ubiquitin ligase membrane-associated RING-CH (MARCH8) as a suppressor of IL-1β-induced NF-κB-and MAPK-activation pathways. Overexpression of MARCH8 inhibits IL-1β-induced NF-κB and MAPK activation, whereas knockdown of MARCH8 has the opposite effect. Mechanistically, MARCH8 interacts with IL1RAP and targets its Lys512 for K48-linked polyubiquitination and degradation. Our findings suggest that MARCH8-mediated polyubiquitination and degradation of IL1RAP is an important mechanism for negative regulation of IL-1β-induced signaling pathways.
The proinflammatory cytokine interleukin-1 (IL-1) signals via type I IL-1 receptor (IL-1RI) and IL-1 receptor accessory protein (IL1RAP), which leads to activation of the transcription factor NF-κB and induction of a range of downstream proteins involved in inflammatory and immune responses. Here, we identified the E3 ubiquitin ligase membrane-associated RING-CH (MARCH8) as a suppressor of IL-1β-induced NF-κB-and MAPK-activation pathways. Overexpression of MARCH8 inhibits IL-1β-induced NF-κB and MAPK activation, whereas knockdown of MARCH8 has the opposite effect. Mechanistically, MARCH8 interacts with IL1RAP and targets its Lys512 for K48-linked polyubiquitination and degradation. Our findings suggest that MARCH8-mediated polyubiquitination and degradation of IL1RAP is an important mechanism for negative regulation of IL-1β-induced signaling pathways.
T he transcription factor NF-κB plays pivotal roles in many aspects of cellular processes such as inflammation, innate immunity, and cancer. NF-κB is sequestered in the cytoplasm and kept inactive in nonstimulated cells by binding to inhibitory IκB (inhibitor of κB) proteins. Under stimulation with cytokines, infectious pathogens, or genotoxic stresses, the IκB proteins are phosphorylated, ubiquitinated, and ultimately degraded, which frees NF-κB for translocation into the nucleus, where it induces transcription of downstream target genes (1) (2) (3) .
Interleukin 1 (IL-1) is a critical proinflammatory cytokine that can trigger a cascade of signaling leading to activation of NF-κB. It functions through engagement of two membrane-bound receptors: IL-1 receptor type I (IL-1RI) and IL-1 receptor accessory protein (IL1RAP) (4) (5) (6) . IL-1RI is the ligand-recognition receptor that binds IL-1β directly (7) . Although IL1RAP does not bind IL-1β directly, its recruitment to IL-1RI following IL-1β stimulation is essential for the formation of an activated membrane receptor complex (8) (9) (10) ). The activated complex can then recruit intracellular adaptor proteins and kinases, including MyD88, IRAK4, and IRAK1 (11) (12) (13) (14) . IRAK4 phosphorylates and activates IRAK1, which in turn recruits TRAF6. IRAK1 and TRAF6 form a complex that is released from the receptor complex (15, 16) . TRAF6 possesses an E3 ubiquitin ligase activity that mediates its autoubiquitination. Ubiquitinated TRAF6 further recruits the TGF-b-activated kinase 1 (TAK1)-TAK1-binding protein 2 (TAB2)-TAB3 complex, resulting in the activation of TAK1. Activated TAK1 subsequently activates downstream kinases IKK-α and IKK-β, which phosphorylate IκB proteins, and lead to activation of NF-κB (17) .
Several studies have suggested that ubiquitination is a central rhythm of regulation of IL-1β-induced NF-κB activation pathways. It has been shown that the E3 ubiquitin ligase TRAF6 mediates K63-linked polyubiquitination of IRAK1 for recruiting IKK and activating NF-κB (18) . Tripartite motif 8 (TRIM8) catalyzes K63-linked polyubiquitination of TAK1, and this promotes the activation of TAK1 (19) . It has also been demonstrated that the E3 ligase Pellino 3b acts as a negative regulator for IL-1 signaling by regulating IRAK degradation (20) . RBCK1 ubiquitinates and downregulates TAB2/3 to negatively regulate IL-1β-induced NF-κB activation (21) .
The membrane-associated RING-CH (MARCH) proteins belong to a recently discovered family of RING-finger ubiquitin ligases. Ten mammalian MARCH gene products have been recognized, and the majority shares a similar structure, including an N-terminal C4HC3-type RING finger (RING-CH finger) and two or more C-terminal transmembrane spans (22, 23) . Several members of this novel E3 ubiquitin ligase family have been shown to ubiquitinate and down-regulate transmembrane proteins, such as major histocompatibility complex class I and II, B7-2, CD166, and ICAM-1 (24) (25) (26) (27) (28) .
In this study, we identified MARCH8 (also called c-MIR and RNF178) as a specific inhibitor of IL-1β-induced NF-κB-activation pathways. Overexpression of MARCH8 caused down-regulation of IL1RAP and inhibited IL-1β-induced NF-κB activation; whereas, knockdown of MARCH8 potentiated IL-1β-induced NF-κB activation. MARCH8 interacted with and targeted IL1RAP at K512 for K48-linked polyubiquitination and degradation. Our findings reveal a negative regulatory mechanism on the control of the early events of IL-1β-induced NF-κB-activation pathways.
Results

Identification of MARCH8 as a Negative Regulator of IL-1β-Induced
Signaling Pathways. The proinflammatory cytokine IL-1β initiates a cascade of signaling events to activate the transcription factor NF-κB (4, 5) . To identify the regulators involved in IL-1β-induced NF-κB-activation signaling pathways, we screened ∼10,000 independent human cDNA clones by NF-κB reporter assays in 293 cells. These efforts led to identification of MARCH8, a member of the MARCH family that was recently discovered to possess E3 ubiquitin ligase activity (22, 23) . In the screening experiments, overexpression of MARCH8 markedly inhibited IL-1β-induced NF-κB activation (Fig. 1A) . Further validation experiments indicated that MARCH8 inhibited IL-1β-induced NF-κB activation in a dose-dependent manner in 293 cells (Fig. 1B) . In similar experiments, MARCH8 had no marked inhibitory effect on TNF-α-and Sendai virus (SeV)-induced NF-κB activation (Fig. 1C) .
Previously, it had been shown that the tryptophan residue at position 114 of MARCH8 is conserved among the MARCH family members and this residue is required for recruitment of E2s for conjugation of ubiquitin moiety to target proteins (29, 30) . To further examine the role of MARCH8 in IL-1β-induced signaling pathways, we examined the effect of MARCH8(W114A) mutant on IL-1β-induced NF-κB activation. As shown in Fig.  1D , MARCH8(W114A) had marked decreased ability to inhibit IL-1β-induced NF-κB activation comparing to its wild-type counterpart, suggesting that the recruitment of E2s is required for MARCH8 to suppress IL-1β-induced NF-κB activation. In quantitative real-time PCR experiments, wild-type MARCH8 inhibited IL-1β-induced transcription of endogenous TNF-α and IκB-α genes; whereas, MARCH8(W114A) had only minimal or no effects (Fig. 1E) . These results together suggest that MARCH8 negatively regulates IL-1β-induced NF-κB activation and transcription of downstream genes. Knockdown of MARCH8 Potentiates IL-1β-Induced NF-κB Activation.
Because overexpression of MARCH8 inhibits IL-1β-induced NF-κB activation, we next examined the role of endogenous MARCH8 in IL-1β-induced signaling. We made two MARCH8 RNAi constructs that target different sites of MARCH8 mRNA. Transient transfection experiments indicated that both of the RNAi constructs could efficiently down-regulate expression of MARCH8 on protein and mRNA levels ( Fig. 2 A and B) . In reporter assays, knockdown of MARCH8 markedly potentiated IL-1β-induced NF-κB activation in 293 cells (Fig. 2C) . Similar results were also found in HeLa cells (Fig. S1 ). In similar experiments, knockdown of MARCH8 had no marked effects on TNF-α-or SeV-induced NF-κB activation (Fig. 2D) . Quantitative real-time PCR experiments demonstrated that knockdown of MARCH8 potentiated IL-1β-induced transcription of endogenous TNF-α and IκB-α genes (Fig. 2E) . These results suggest that MARCH8 is a physiological suppressor of IL-β-induced NF-κB-activation pathways.
MARCH8 Negatively Regulates IL-1β-Induced NF-κB Activation by Destabilizing IL1RAP. The MARCH family is a family of membrane-bound E3 ubiquitin ligases, and several members of this family have been reported to regulate the turnover of cargo proteins. To elucidate the mechanism by which MARCH8 functions to negatively regulate the IL-1β-induced NF-κB-activation pathways, we examined whether MARCH8 could regulate the turnover of some key components in IL-1β-induced NF-κB-activation pathways. In transient transfection and immunoblot experiments, we found that the protein level of IL1RAP but not IL-1RI, MyD88, IRAK1, or TRAF6 was dramatically downregulated when coexpressed with MARCH8 (Fig. 3A) . In addition, compared with wild-type MARCH8, MARCH8(W114A) failed to cause obvious down-regulation of IL1RAP (Fig. 3B) . This result is consistent with previous finding that MARCH8 (W114A) had only minimal inhibitory effect on IL-1β-induced NF-κB activation. We next examined the effect of knockdown of MARCH8 on expression of endogenous IL1RAP. The results showed that knockdown of MARCH8 up-regulated the level of endogenous IL1RAP (Fig. 3C) .
IL1RAP is an essential component of the IL-1 coreceptor complex required for IL-1β-induced signaling (8) (9) (10) . Coexpression of IL1RAP and IL-1RI can mimic IL-1β stimulation for activation of NF-κB (Fig. S2) . As MARCH8 could down-regulate the expression of IL1RAP, we examined the effect of MARCH8 on NF-κB activation mediated by coexpression of IL1RAP and IL-1RI. In reporter experiments, overexpression of MARCH8 inhibited NF-κB activation mediated by coexpression of IL1RAP and IL-1RI in a dose-dependent manner ( Fig. 3 D and E) . In parallel experiments, overexpression of MARCH8 had no obvious effect on NF-κB activation induced by overexpression of downstream components IRAK1 or TRAF6 (Fig. 3D) . These results suggest that MARCH8 inhibits IL-1β-induced NF-κB activation by mediating down-regulation of IL1RAP.
MARCH8 Interacts with IL1RAP. Because MARCH8 could cause down-regulation of IL1RAP, we examined whether MARCH8 physically interacts with IL1RAP in mammalian cells. In transient transfection and coimmunoprecipitation experiments, MARCH8 interacted with IL1RAP as well as IL-1RI in 293 cells (Fig. 4A) . Endogenous coimmunoprecipitation experiments showed that MARCH8 constitutively interacted with IL1RAP either in absence or presence of IL-1β treatment (Fig. 4B) . In addition to coimmunoprecipitation experiments, we also showed by confocal microscopy experiments that MARCH8 was colocalized with IL1RAP at the plasma membrane and in the cytoplasm in HeLa (Fig. 4C) or 293 (Fig. S3) .
IL1RAP is a transmembrane protein that contains an Nterminal extracellular domain, a transmembrane domain and a C-terminal cytosolic Toll/Interleukin-1 receptor (TIR) domain. We constructed a series of IL1RAP deletion mutants and performed domain mapping experiments. The results indicated that the transmembrane domain of IL1RAP was required for its interaction with MARCH8 (Fig. S4A) . In similar experiments, we found that the first transmembrane domain and the region between two the transmembrane domains of MARCH8 were important for its interaction with IL1RAP (Fig. S4B) .
MARCH8 Mediates K48-Linked Polyubiquitination of IL1RAP. Because MARCH8 is an E3 ubiquitin ligase and its recruitment for E2 is critical for inhibition of IL-1β-induced NF-κB activation, we predicted that MARCH8 could mediate ubiquitination of IL1RAP. To test this, expression plasmids for IL1RAP-GFP and HA-ubiquitin were transfected together with wild-type MARCH8, MARCH8 (W114A), or empty control plasmid. Coimmunoprecipitation experiments showed that overexpression of wild-type MARCH8 but not MARCH8(W114A) caused polyubiquitination and downregulation of IL1RAP (Fig. 4D) . Using linkage-specific ubiquitin, we showed that overexpression of MARCH8 promoted K48-linked but not K63-linked polyubiquitination of IL1RAP (Fig. 4E) . Furthermore, in vitro ubiquitination assays with UBC5C as an E2 also confirmed that wild-type MARCH8 but not MARCH8(W114A) could effectively ubiquitinate IL1RAP (Fig. 4F) . These data suggest that MARCH8 directly mediates K48-linked ubiquitination of IL1RAP to facilitate its degradation.
MARCH8 Targets K512 of IL1RAP for Polyubiquitination. To identify potential ubiquitination residues of IL1RAP, we first mapped the region targeted by MARCH8. We found that aa365-570 but not other truncations of IL1RAP were down-regulated and ubiquitinated by MARCH8 (Fig. 5 A and B) . These results suggest that MARCH8 targets the C-terminal region of IL1RAP for ubiquitination and degradation. We then mutated all of the 18 lysine residues identified in the C-terminal region to arginine individually and examined whether they can still be ubiquitinated by MARCH8. Cotransfection and immunoblot experiments showed that the level of IL1RAP(K512R) was not affected by MARCH8, whereas the levels of wild-type and the other 17 mutant IL1RAP were down-regulated by MARCH8 (Figs. 5C  and Fig. S5 ). Consistently, in ubiquitination experiments, MARCH8 enhanced the polyubiquitination level of wild-type IL1RAP but not IL1RAP(K512R) (Fig. 5D) . When wild-type IL1RAP and IL1RAP(K512R) were reconstituted into IL1RAP knockdown cells, IL1RAP(K512R) showed an increased ability to mediate IL-1β-induced activation of NF-κB than wild-type IL1RAP (Fig.  S6) . Taken together, these data suggest that MARCH8 targets K512 of IL1RAP for ubiquitination and degradation.
MARCH8 Negatively Regulates IL-1β-Induced MAPK Pathways. In addition to NF-κB activation, IL-1β stimulation also leads to activation of MAPK pathways including Extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. We performed experiments to determine whether MARCH8 also regulates these pathways. We found that overexpression of MARCH8 inhibited IL-1β-induced phosphorylation of JNK, p38, and ERK (Fig. 6A) , whereas knockdown of MARCH8 enhanced IL-1β-induced phosphorylation of these kinases (Fig. 6B) . Consistent with our earlier observations, overexpression of MARCH8 also inhibited IL-1β-induced phosphorylation and degradation of IκBα; whereas, knockdown of MARCH8 had opposite effects (Fig. 6) . To further confirm the regulation of MARCH8 on IL-1β-induced MAPK signaling, we examined the effects of MARCH8 on expression of MAPK-responsive genes. The results showed that overexpression of MARCH8 inhibited transcription of IL8, EGR1, and MKP-1 genes (Fig. S7A) , and knockdown of MARCH8 enhanced their transcription (Fig. S7B) . These data suggest that MARCH8 negatively regulates IL-1β-induced MAPK signaling pathways.
MARCH8 Attenuates the Assembly of IL-1R-Proximal Signaling Complex.
Because MARCH8 targets at IL1RAP level to inhibit IL-1β-induced signaling, we next examined the effects of MARCH8 on assembly of IL-1β-initiated IL-1R-proximal signaling complex. We transfected the 293 cells with Flag-tagged IL-1RI, Myc-tagged MyD88, and HA-tagged IRAK1 combined with empty vector or HA-tagged MARCH8, and performed coimmunoprecipitation experiments. The results showed that overexpression of MARCH8 attenuated IL-1β-induced interaction between IL-1RI and MyD88 or IRAK1 (Fig. S8) . This data suggest that MARCH8 inhibits the assembly of IL-1R-proximal signaling complex.
Discussion
The transcription factor NF-κB plays pivotal roles in a broad range of physiological and pathological processes, such as development, immune response, inflammation, and cancer (31) . IL-1β is a potent proinflammatory cytokine that can strongly elicit activation of NF-κB (4, 5) . However, this NF-κB-activation process needs to be tightly regulated to keep inflammatory homeostasis. In a screening for regulators of IL-1β-induced activation of NF-κB, we identified MARCH8, a member of the MARCH family proteins.
Overexpression of MARCH8 inhibited IL-1β-induced NF-κB activation, whereas knockdown of MARCH8 potentiated IL-1β-induced activation of NF-κB. In similar experiments, neither overexpression nor knockdown of MARCH8 had marked effects on TNF-α-or SeV-induced activation of NF-κB. These results suggest that MARCH8 is a specific inhibitor of IL-1β-induced NF-κB-activation pathways.
Overexpression of MARCH8 caused substantial down-regulation of IL1RAP and inhibition of IL1RAP-mediated NF-κB activation. However, MARCH8 had no obvious effects on IRAK1-, TRAF6-, or TNFR1-triggered NF-κB activation. Further coimmunoprecipitation and confocal microscopy experiments showed that MARCH8 can physically interact and colocalize with IL1RAP in the absence and presence of IL-1β, which suggests that MARCH8 constitutively targets IL1RAP for degradation to inhibit IL-1β-induced NF-κB activation.
Ubiquitination plays important roles in different steps of NF-κB activation. It has been shown that MARCH8 is a RING finger E3 ubiquitin ligase, and the W114 is a conserved site among MARCH family and many other RING finger E3 ubiquitin ligases that directly involved in E2 recruitment (30, 32) . Correspondingly, overexpression of wild-type MARCH8 but not ligase-deficient mutant MARCH8(W114A) caused the ubiquitination and degradation of IL1RAP. Using link-specific ubiquitin, we identified that MARCH8 catalyzed K48-linked but not K63-linked polyubiquitination of IL1RAP. In the in vitro ubiquitination assays, we found that Ubiquitin-conjugating enzyme 5b/5c (UBCH5b/5c) were specific E2 enzymes for IL1RAP ubiquitination. Further site-directed mutagenesis experiments indicated that MARCH8 ubiquitinated IL1RAP at K512. Although it has been known that ubiquitination is involved in regulation of IL-1β-induced signaling pathways, however, as a key step of IL-1β-initiated signaling, whether the IL-1 receptor complex could also be regulated by ubiquitination is unknown. Our study provides evidence that IL-1β-induced NF-κB-activation pathways are regulated by ubiquitination at the IL1RAP coreceptor level.
Our results indicated that overexpression of MARCH8 inhibited IL-1β-induced activation of ERK, JNK, and p38; whereas, knockdown of MARCH8 had opposite effect. These results suggest that MARCH8 also regulates IL-1β-induced MAPK pathways. This further supports our conclusion that MARCH8 targets IL1RAP, a coreceptor that mediates both IL-1β-induced NF-κB and MAPK pathways.
In confocal microscopy experiments, we found that in addition to plasma membrane, overexpressed MARCH8 and IL1RAP were also colocalized in the cytoplasm. Previously, it has been demonstrated that IL-1β-induced internalization of IL-1RI and IL1RAP requires ubiquitination of these proteins (33) . In light of this published study, it would be interesting to elucidate whether MARCH8-mediated polyubiquitination is required for internalization of the IL-1 receptor complex.
In our experiments, we have also routinely noticed that MARCH8 causes faster migration of IL1RAP. The simplest explanation for this observation is that MARCH8, either directly or indirectly, causes decreased posttranslational modifications of IL1RAP. More experiments are needed in the future to elucidate the mechanisms behind this observation.
IL-1β-induced NF-κB and MAPK activation contributes to inflammatory response. However, this process must be tightly regulated to avoid damaging inflammatory and autoimmune diseases. So far, a number of modulators of IL-1β-induced signaling pathways have been reported (20, 34) . Our findings identified MARCH8 as a negative regulator of IL-1β-induced NF-κB-activation pathway that targets at the IL1RAP coreceptor level. In addition to IL-1, IL1RAP is also known to be a coreceptor for IL-33 and IL-36 (35) (36) (37) . In this context, it is possible that MARCH8 might also target IL1RAP to negatively regulate signaling by these two IL-1 family members. Our findings help to understand the complicated regulatory mechanisms of IL-1 familymediated inflammatory processes and may provide potential therapeutic target for controlling the homeostasis of inflammation.
Materials and Methods
Reagents and Constructs. The reagents and constructs used in this study are described in SI Materials and Methods.
Coimmunoprecipitation and Immunoblot Analysis. Transfected 293 cells from each 10-cm dish were lysed in l ml Nonidet P-40 lysis buffer (20 mM Tris-HCl, PH 7.4-7.5, 150 mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 10 μg/mL aprotinin, 10 μg/mL leupeptin, and 1 mM phenylmethylsulfonyl fluoride). For each immunoprecipitation, 0.8 mL cell lyaste was incubated with 0.5 μg of the indicated antibody and 25 μL of 50% (vol/vol) slurry of GammaBind G PlusSepharose (Amersham Biosciences) at 4°C for 2 h. The Sepharose beads were washed three times with 1 mL lysis buffer containing 500 mM NaCl. The precipitates were fractionated by SDS/PAGE and subsequent immunoblot analysis was performed with the indicated antibody.
Reimmunoprecipitation Experiments. Reimmunoprecipitation experiments were performed as described (38, 39) . Briefly, after first-round immunoprecipitation, the immunoprecipitates were reextracted in lysis buffer containing 1% SDS and denatured by heating for 5 min. The sample was diluted with regular lysis buffer till the concentration of SDS was decreased to 0.1%. The diluted sample was reimmunoprecipitated with the indicated antibody, and the immunoprecipitates were analyzed by immunoblot with anti-HA.
Transfection, Reporter Assays, RNAi Experiments, and Real-Time PCR. These procedures are described in SI Materials and Methods.
Fluorescent Confocal Microscopy. The 293 or HeLa cells were transfected with the indicated plasmids by Fugene HD (Roche). At 24 h after transfection, the cells were fixed with 4% paraformaldehyde for 15 min at 4°C. The cells were then observed with a Leica confocal microscope under a ×100 oil objective.
In Vitro Ubiquitination Assays. The tested proteins were expressed with a TNT Quick Coupled Transcription/Translation Systems kit (Promega) following instructions of the manufacturer. Ubiquitination was analyzed with an ubiquitination kit (Enzo Life Sciences) following protocols recommended by the manufacture. 
